The transition from relapsing-remitting MS to irreversible disability: clinical evaluation

被引:0
|
作者
M. Trojano
D. Paolicelli
A. Bellacosa
S. Cataldo
机构
[1] University of Bari,Department of Neurological and Psychiatric Sciences
来源
Neurological Sciences | 2003年 / 24卷
关键词
Multiple sclerosis; Disease duration; Prognosis; Age; Disability progression;
D O I
暂无
中图分类号
学科分类号
摘要
The development of a progressive course is by far the most deleterious event in the case of a multiple sclerosis (MS) patient. It occurs in about 90% of relapsing remitting patients by 20–25 years from onset. The clinical transition to secondary progressive MS is phenotypically distinctive and both patients and physicians acknowledge that a fundamental shift in the degree of responsiveness to anti-inflammatory therapies has occurred. This review discusses the clinical studies that provided important findings relating to our understanding on different mechanisms that may contribute to irreversible disability in MS.
引用
收藏
页码:s268 / s270
相关论文
共 50 条
  • [41] Heterogeneous impact of an early IFN beta treatment on disability progression in relapsing-remitting MS subgroups with different baseline clinical profiles
    Trojano, M.
    Amato, M. P.
    Avolio, C.
    Bergamaschi, R.
    Cavalla, P.
    Comi, G.
    Durelli, L.
    Fuiani, A.
    Ghezzi, A.
    Giuliani, G.
    Lugaresi, A.
    Lus, G.
    Millefiorini, E.
    Paolicelli, D.
    Patti, F.
    Pellegrini, F.
    Pozzilli, C.
    Salemi, G.
    Vianello, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S59 - S59
  • [42] Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis
    Young, P. J.
    Lederer, C.
    Eder, K.
    Daumer, M.
    Neiss, A.
    Polman, C.
    Kappos, L.
    NEUROLOGY, 2006, 67 (05) : 804 - 808
  • [43] The long term clinical course of relapsing-remitting MS: prognosis factors in Brazilian population
    Ferreira Vasconcelos, Claudia Cristina
    Cruz Dos Santos, Gutemberg Augusto
    Santos Thuler, Luiz Claudio
    Das Gracas Dos Santos Camargo, Solange Maria
    Papais Alvarenga, Regina Maria
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1867 - 1867
  • [44] MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients
    Sormani, MP
    Bruzzi, P
    Comi, G
    Filippi, M
    NEUROLOGY, 2002, 58 (03) : 417 - 421
  • [45] Clinical and molecular markers that predict severity of relapsing-remitting MS (RRMS) disease outcomes
    Goyal, J.
    Bienkowska, J.
    Hosur, R.
    Yang, M.
    Feng, S.
    Viglietta, V.
    Mikol, D.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 400 - 401
  • [46] MRI cerebral atrophy in relapsing-remitting MS: Results from the PRISMS trial
    Jones, CK
    Riddehough, A
    Li, DKB
    Zhao, GJ
    Paty, DW
    NEUROLOGY, 2001, 56 (08) : A379 - A379
  • [47] Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
    Bianca Weinstock-Guttman
    Steven L. Galetta
    Gavin Giovannoni
    Eva Havrdova
    Michael Hutchinson
    Ludwig Kappos
    Paul W. O’Connor
    J. Theodore Phillips
    Chris Polman
    William H. Stuart
    Frances Lynn
    Christophe Hotermans
    Journal of Neurology, 2012, 259 : 898 - 905
  • [48] Safety and Impact on Disease Outcomes of Natalizumab in Patients with Relapsing-Remitting MS in Clinical Practice
    Butzkueven, Helmut
    Kappos, Ludwig
    Trojano, Maria
    Wiendl, Heinz
    Pellegrini, Fabio
    Belachew, Shibeshih
    Pace, Amy
    Desgrandchamps, Daniel
    NEUROLOGY, 2010, 74 (09) : A66 - A66
  • [49] Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years
    Zivadinov, R.
    Bergsland, N.
    Dolezal, O.
    Hussein, S.
    Seidl, Z.
    Dwyer, M. G.
    Vaneckova, M.
    Krasensky, J.
    Potts, J. A.
    Kalincik, T.
    Havrdova, E.
    Horakova, D.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (10) : 1931 - 1939
  • [50] Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
    Weinstock-Guttman, Bianca
    Galetta, Steven L.
    Giovannoni, Gavin
    Havrdova, Eva
    Hutchinson, Michael
    Kappos, Ludwig
    O'Connor, Paul W.
    Phillips, J. Theodore
    Polman, Chris
    Stuart, William H.
    Lynn, Frances
    Hotermans, Christophe
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 898 - 905